deflazacort has been researched along with Hepatitis, Autoimmune in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bae, SH; Kim, DH; Kim, JS | 1 |
| Caunedo Alvarez, A; Cifuentes Mimoso, C; Herrerías Gutiérrez, J; Jiménez-Sáenz, M; Piñar Moreno, A; Rebollo Bernárdez, J; Salas Herrero, E | 1 |
1 trial(s) available for deflazacort and Hepatitis, Autoimmune
| Article | Year |
|---|---|
Deflazacort for long-term maintenance of remission in type I autoimmune hepatitis.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Female; Hepatitis, Autoimmune; Humans; Immunoglobulin G; Male; Middle Aged; Pregnenediones; Secondary Prevention | 1999 |
1 other study(ies) available for deflazacort and Hepatitis, Autoimmune
| Article | Year |
|---|---|
Deflazacort for type-1 autoimmune hepatitis in a Korean girl.
Topics: Child; Cholagogues and Choleretics; Drug Therapy, Combination; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Korea; Pregnenediones; Treatment Outcome; Ursodeoxycholic Acid | 2006 |